134 related articles for article (PubMed ID: 38653151)
1. Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E
Gür Maz T; Dahlke P; Gizem Ergül A; Olğaç A; Jordan PM; Çalışkan B; Werz O; Banoglu E
Bioorg Chem; 2024 Jun; 147():107383. PubMed ID: 38653151
[TBL] [Abstract][Full Text] [Related]
2. Structure-based screening for the discovery of 1,2,4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid biosynthesis pathways.
Potenza M; Sciarretta M; Chini MG; Saviano A; Maione F; D'Auria MV; De Marino S; Giordano A; Hofstetter RK; Festa C; Werz O; Bifulco G
Eur J Med Chem; 2021 Nov; 224():113693. PubMed ID: 34315041
[TBL] [Abstract][Full Text] [Related]
3. Rotational constriction of curcuminoids impacts 5-lipoxygenase and mPGES-1 inhibition and evokes a lipid mediator class switch in macrophages.
Rao Z; Caprioglio D; Gollowitzer A; Kretzer C; Imperio D; Collado JA; Waltl L; Lackner S; Appendino G; Muñoz E; Temml V; Werz O; Minassi A; Koeberle A
Biochem Pharmacol; 2022 Sep; 203():115202. PubMed ID: 35932797
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E
Cheung SY; Werner M; Esposito L; Troisi F; Cantone V; Liening S; König S; Gerstmeier J; Koeberle A; Bilancia R; Rizza R; Rossi A; Roviezzo F; Temml V; Schuster D; Stuppner H; Schubert-Zsilavecz M; Werz O; Hanke T; Pace S
Eur J Med Chem; 2018 Aug; 156():815-830. PubMed ID: 30053720
[TBL] [Abstract][Full Text] [Related]
5. Novel potent benzimidazole-based microsomal prostaglandin E
Ergül AG; Maz TG; Kretzer C; Olğaç A; Jordan PM; Çalışkan B; Werz O; Banoglu E
Eur J Med Chem; 2022 Mar; 231():114167. PubMed ID: 35152061
[TBL] [Abstract][Full Text] [Related]
6. A review on mPGES-1 inhibitors: From preclinical studies to clinical applications.
Bergqvist F; Morgenstern R; Jakobsson PJ
Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106383. PubMed ID: 31698145
[TBL] [Abstract][Full Text] [Related]
7. Natural products as inhibitors of prostaglandin E
Koeberle A; Werz O
Biotechnol Adv; 2018 Nov; 36(6):1709-1723. PubMed ID: 29454981
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE
Martin EM; Jones SL
Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 2,5-disubstituted 1,3,4-oxadiazole derivatives with both COX and LOX inhibitory activity.
Akhter M; Akhter N; Alam MM; Zaman MS; Saha R; Kumar A
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):767-76. PubMed ID: 21314246
[TBL] [Abstract][Full Text] [Related]
10. Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1.
Akasaka H; Ruan KH
Arch Biochem Biophys; 2016 Aug; 603():29-37. PubMed ID: 27177970
[TBL] [Abstract][Full Text] [Related]
11. Polysubstituted Pyrimidines as mPGES-1 Inhibitors: Discovery of Potent Inhibitors of PGE
Kalčic F; Kolman V; Ajani H; Zídek Z; Janeba Z
ChemMedChem; 2020 Aug; 15(15):1398-1407. PubMed ID: 32410351
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
[TBL] [Abstract][Full Text] [Related]
13. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of COX-2/mPGES-1 and 5-LOX in macrophages by leonurine ameliorates monosodium urate crystal-induced inflammation.
Liu Y; Duan C; Chen H; Wang C; Liu X; Qiu M; Tang H; Zhang F; Zhou X; Yang J
Toxicol Appl Pharmacol; 2018 Jul; 351():1-11. PubMed ID: 29763636
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
Koeberle A; Werz O
Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
[TBL] [Abstract][Full Text] [Related]
16. Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: A promising pharmacological strategy for anti-inflammatory therapy.
Gerstmeier J; Kretzer C; Di Micco S; Miek L; Butschek H; Cantone V; Bilancia R; Rizza R; Troisi F; Cardullo N; Tringali C; Ialenti A; Rossi A; Bifulco G; Werz O; Pace S
Biochem Pharmacol; 2019 Jul; 165():263-274. PubMed ID: 30836057
[TBL] [Abstract][Full Text] [Related]
17. Identification of multi-target inhibitors of leukotriene and prostaglandin E
Gür ZT; Çalışkan B; Garscha U; Olgaç A; Schubert US; Gerstmeier J; Werz O; Banoglu E
Eur J Med Chem; 2018 Apr; 150():876-899. PubMed ID: 29597170
[TBL] [Abstract][Full Text] [Related]
18. Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy.
Gürses T; Olğaç A; Garscha U; Gür Maz T; Bal NB; Uludağ O; Çalışkan B; Schubert US; Werz O; Banoglu E
Bioorg Chem; 2021 Jul; 112():104861. PubMed ID: 33826984
[TBL] [Abstract][Full Text] [Related]
19. Discovery of N-amido-phenylsulfonamide derivatives as novel microsomal prostaglandin E
Kim M; Kim G; Kang M; Ko D; Nam Y; Moon CS; Kang HM; Shin JS; Werz O; Lee KT; Lee JY
Bioorg Med Chem Lett; 2021 Jun; 41():127992. PubMed ID: 33775835
[TBL] [Abstract][Full Text] [Related]
20. Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1.
Koeberle A; Haberl EM; Rossi A; Pergola C; Dehm F; Northoff H; Troschuetz R; Sautebin L; Werz O
Bioorg Med Chem; 2009 Dec; 17(23):7924-32. PubMed ID: 19884011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
